Free Trial

LivaNova (LIVN) Competitors

LivaNova logo
$36.79 -0.21 (-0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$36.78 -0.01 (-0.01%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LIVN vs. STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, TMDX, PRCT, and NVST

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.

LivaNova vs.

Stevanato Group (NYSE:STVN) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, community ranking, institutional ownership, analyst recommendations, profitability and media sentiment.

In the previous week, LivaNova had 4 more articles in the media than Stevanato Group. MarketBeat recorded 10 mentions for LivaNova and 6 mentions for Stevanato Group. LivaNova's average media sentiment score of 1.45 beat Stevanato Group's score of 1.18 indicating that LivaNova is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
8 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has a net margin of 10.47% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group10.47% 9.86% 5.79%
LivaNova 1.91%13.81%7.07%

LivaNova received 374 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 69.71% of users gave LivaNova an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
Stevanato GroupOutperform Votes
31
63.27%
Underperform Votes
18
36.73%
LivaNovaOutperform Votes
405
69.71%
Underperform Votes
176
30.29%

Stevanato Group has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500.

97.6% of LivaNova shares are held by institutional investors. 0.7% of Stevanato Group shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Stevanato Group has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group$1.10B5.71$157.62M$0.4843.33
LivaNova$1.25B1.60$17.55M$1.1432.46

LivaNova has a consensus target price of $61.17, indicating a potential upside of 65.32%. Given LivaNova's stronger consensus rating and higher possible upside, analysts plainly believe LivaNova is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86
LivaNova
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.88

Summary

LivaNova beats Stevanato Group on 14 of the 18 factors compared between the two stocks.

Get LivaNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.01B$3.21B$5.56B$7.82B
Dividend YieldN/A1.80%5.11%4.22%
P/E Ratio88.1015.4222.5718.48
Price / Sales1.6052.69395.64103.60
Price / Cash11.1544.0938.1834.62
Price / Book1.563.526.774.25
Net Income$17.55M$94.03M$3.22B$248.23M
7 Day Performance-0.70%0.99%1.46%0.89%
1 Month Performance-5.20%4.39%3.98%3.53%
1 Year Performance-40.91%-18.35%16.14%5.09%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIVN
LivaNova
3.8227 of 5 stars
$36.79
-0.6%
$61.17
+66.3%
-33.6%$2.00B$1.25B87.602,900Upcoming Earnings
News Coverage
Positive News
STVN
Stevanato Group
1.1526 of 5 stars
€21.65
-1.0%
N/A-25.8%$6.56B$1.10B46.064,650Positive News
GKOS
Glaukos
4.8044 of 5 stars
$88.17
-2.3%
$156.17
+77.1%
-1.7%$4.99B$383.48M-30.72780Earnings Report
Analyst Forecast
News Coverage
Positive News
Gap Down
NARI
Inari Medical
N/A$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800
INSP
Inspire Medical Systems
4.8547 of 5 stars
$144.74
-3.6%
$218.90
+51.2%
-34.4%$4.31B$802.80M83.67760Upcoming Earnings
BLCO
Bausch + Lomb
3.7046 of 5 stars
$12.05
-0.1%
$18.82
+56.2%
-20.4%$4.26B$4.79B-13.2412,500Earnings Report
Analyst Forecast
News Coverage
SLNO
Soleno Therapeutics
4.6429 of 5 stars
$68.93
-1.5%
$99.63
+44.5%
+67.6%$3.16BN/A-20.7630Upcoming Earnings
Positive News
IRTC
iRhythm Technologies
0.9603 of 5 stars
$98.63
-2.3%
$119.73
+21.4%
-2.5%$3.10B$591.84M-27.101,790News Coverage
TMDX
TransMedics Group
3.1869 of 5 stars
$87.72
-0.6%
$122.70
+39.9%
-2.3%$2.97B$441.54M93.32210Upcoming Earnings
Analyst Forecast
PRCT
PROCEPT BioRobotics
2.7234 of 5 stars
$53.43
+0.8%
$91.43
+71.1%
+1.9%$2.93B$224.50M-27.40430Earnings Report
Analyst Revision
Positive News
High Trading Volume
NVST
Envista
3.9412 of 5 stars
$14.88
-2.0%
$19.96
+34.2%
-18.3%$2.56B$2.51B-2.2912,700Earnings Report
Analyst Forecast
Positive News

Related Companies and Tools


This page (NASDAQ:LIVN) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners